Nucleic Acid Blood Screening Market Size to Reach US$ 7.53 Billion by 2031, Growing at CAGR 7.9%

Los Angeles, United State: A newly published report titled "Global Nucleic Acid Blood Screening Market Insights, Forecast 2025 to 2031" by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The Nucleic Acid Blood Screening report also highlights the key driving factors and restraints that are impacting the growth. For a comprehensive understanding, the professionals have reviewed the regulatory scenario, market entry strategies, best industry practices, pricing strategy, technology landscape, and consumption, sales, and demand outlook.

The global Nucleic Acid Blood Screening market was valued at US$ 4.43 billion in 2024 and is anticipated to reach US$ 7.53 billion by 2031, witnessing a CAGR of 7.9% during the forecast period 2025-2031.

Download Exclusive PDF Sample: (Including Full TOC, Data Tables, Visual Charts) @ https://qyresearch.in/request-sample/medical-devices-consumables-global-nucleic-acid-blood-screening-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

Nucleic acid blood screening is a blood safety detection method based on molecular biology technology. Its core lies in the early diagnosis and risk elimination of viral, bacterial and other pathogen infections by specifically amplifying and detecting the nucleic acid sequences (DNA or RNA) of pathogens in blood samples. This technology uses nucleic acid amplification detection (NAT) platforms (such as real-time fluorescence quantitative PCR, transcription-mediated amplification, etc.) to identify extremely low concentrations of pathogen nucleic acids in the blood with high sensitivity and specificity. It is particularly suitable for screening samples in the "window period" of infection that cannot be covered by traditional serological tests, thereby significantly reducing the risk of transfusion-transmitted infections (TTIs) and ensuring the safety of clinical blood use. Its detection targets include blood-borne disease pathogens such as HBV, HCV, and HIV, and has become a key link in blood quality control in modern transfusion medicine.

The current nucleic acid blood screening market is showing a steady growth trend worldwide. The North American market is dominant due to the popularization of nucleic acid detection technology and policy support, while the Asia-Pacific region has become the fastest growing region due to its aging population, increased medical expenditures and improved infrastructure. On the technical level, NAT (nucleic acid amplification detection) occupies the largest market share, and its high sensitivity drives the demand of end users such as blood banks and hospitals. Emerging economies such as India, the Middle East and Africa show high growth potential due to increased medical spending and disposable income, but challenges such as high technology costs and shortage of skilled personnel still restrict market development. In the future, with the iteration of testing technology and the increasing global attention to blood safety, the market is expected to usher in opportunities for continued expansion.

Featured Companies: -

Roche
Grifols Diagnostic Solutions
KHB
Bacme Bio
Daan Gene
Wantai Biotechnology
Sansure Biotech
Zhuhai Livzon Reagents
Bio-Rad Laboratories
Horiba
Thermo Fisher Scientific
bioMerieux
Danaher
Abbott
BD
Mindray

Why This Report is a Must-Have -

> Historical Analysis (2020-2024) & Forecasts (2025-2031): Gain a clear understanding of market trends and future growth potential.

> Comprehensive Market Segmentation: Detailed breakdown by Type, Application, and Region to identify lucrative opportunities.

> Competitive Landscape: Insights into key players, their market share, and strategic developments like mergers, acquisitions, and expansion plans.

> Drivers & Restraints: Understand the factors shaping the market's growth and the challenges that could impact your strategy.

> Expert Opinions & Market Dynamics: Benefit from expert analysis to navigate market risks and capitalize on emerging trends.

Detailed of Nucleic Acid Blood Screening Market Segmentation: -

Segmentation By Type :-

Blood Screening Equipment
blood Screening Reagents

Segmentation By Application : -

Blood Center
Central Blood Station
Central Blood Bank

Nucleic Acid Blood Screening Market Regional Insights -

United States

-Canada
-Mexico
-Brazil

APAC

-Japan
-South Korea
-China
-ASEAN
-India

EMEA

-Europe
-Middle East
-Africa

Request for Pre-Order Enquiry On This Exclusive Report @ https://qyresearch.in/pre-order-inquiry/medical-devices-consumables-global-nucleic-acid-blood-screening-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

What You'll Gain from This Report -

> In-Depth Regional Analysis: Explore market potential across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

> Competitive Intelligence: Profiles of key players, including their sales, revenue, product portfolios, and recent developments.

> Market Dynamics: Understand the latest trends, driving factors, and risks impacting the industry.

> Actionable Insights: Make informed business decisions with data-driven strategies and forecasts.

How Can the Research Study Help your Business?

(1) The information presented in the Nucleic Acid Blood Screening report helps your decision makers to become prudent and make the best business choices.

(2) The report enables you to see the future of the global Nucleic Acid Blood Screening market and accordingly take decisions that will be in the best interest of your business.

(3) It offers you a forward-looking perspective of the global Nucleic Acid Blood Screening market drivers and how you can secure significant market gains in the near future.

(4) It provides SWOT analysis of the global Nucleic Acid Blood Screening market along with useful graphics and detailed statistics providing quick information about the market's overall progress throughout the forecast period.

(5) It also assesses the changing competitive dynamics of the global Nucleic Acid Blood Screening market using pin-point evaluation.

This Nucleic Acid Blood Screening Market Research Report Contains Answers to your following Questions -

(A) Which Manufacturing Technology is Used for Nucleic Acid Blood Screening? What Developments Are Going On in That Technology? Which Trends Are Causing These Developments?

(B) Who Are the Global Key Players in This Nucleic Acid Blood Screening Market? What's Their Company Profile, Their Product Information, and Contact Information?

(C) What Was Global Market Status of Nucleic Acid Blood Screening Market? What Was Capacity, Production Value, Cost and PROFIT of Nucleic Acid Blood Screening Market?

(D) What Is Current Market Status of Nucleic Acid Blood Screening Industry? What's Market Competition in This Industry, Both Company, and Country Wise? What's Market Analysis of Nucleic Acid Blood Screening Market by Taking Applications and Types in Consideration?

(E) What Are Projections of Global Nucleic Acid Blood Screening Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?

(F) What Is Nucleic Acid Blood Screening Market Chain Analysis by Upstream Raw Materials and Downstream Industry?

(G) What Is Economic Impact On Nucleic Acid Blood Screening Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?

(H) What Are Market Dynamics of Nucleic Acid Blood Screening Market? What Are Challenges and Opportunities?

(I) What Should Be Entry Strategies, Countermeasures to Economic Impact, Marketing Channels for Nucleic Acid Blood Screening Industry?

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Nucleic Acid Blood Screening manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Sales, revenue of Nucleic Acid Blood Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.